How transformational leadership and advanced technologies foster radical innovation : the role of advanced training, organisational learning, innovative climate and capabilities in large firms

University of Technology Sydney. Faculty of Business.Radical innovation is a key enabler to sustained competitive advantage and long-term success of firms. Despite its importance, there is lack of understanding of what components of a firm are able to best promote this type of innovation in dynamic market environments. Drawing on the dynamic capability theory, this study investigates how transformational leadership as a ‘human factor’ and advanced technology as a ‘machinery factor’ can ‘in parallel’ encourage radical innovation. This study proposes a conceptual framework and empirically tests path-dependent influences of: transformational leadership, advanced technology, advanced training, organisational learning, innovative climate and innovation capability on radical innovation within the specific sphere of large Saudi firms. To fulfil the purpose of this study, a deductive approach was used, and the unit of analysis was at the individual level to examine the hypothesised relationships between factors. Focus group discussions and a pilot-test are applied to ensure content appropriateness and validity of the measurement items in the tested model. The sample for this study consists of seven large firms in four different sectors. The target population includes only employees working in innovative activities in large firms who have first-hand knowledge of organisational features that contribute to the innovation processes. Data were collected via an online survey from seven large Saudi firms in four different sectors, resulting in 237 usable responses for analysis. The hypotheses were examined by employing Structural Equation Modelling (SEM) with the statistical software program AMOS version 24. The conceptual framework of the study was affirmed and supported by empirical results. The results indicate that both transformational leadership and advanced technology are two significant determiners for successful radical innovation in large firms. The findings reveal that both transformational leadership and advanced technology enhance the positive effects of organisational learning and advanced training on innovative climate. An improved innovative climate then has a direct positive influence on innovation capability, which promotes radical innovation. This study contributes to the existing body of the innovation literature by explicating the parallel effect of transformational leadership and advanced technology on cultivation of the innovation capabilities necessary for radical innovation. It enriches the existing literature by explaining how transformational leadership and advanced technology influence organisational learning, advanced training, and innovative climate to create innovation capabilities respectively. Moreover, it contributes to the innovation literature by identifying and addressing that innovative climate is a significant mediating factor on the relationship between both of advanced training and organisational learning on innovation capability. The findings of this study offer a set of implications for practitioners and executives to assist them to support radical innovation outcomes through, for instance, recruiting for and/or developing a preferred leadership style, how technology might be deployed, and ways to configure these in order to produce a more innovative climate in the organisation. Finally, the current study provides a number of avenues for future research on similar topics, including the suggestion to replicate this study within different settings, including other Arabian Gulf and Middle Eastern countries

DESIGN AND EVALUATION OF FAST DISSOLVING GRANULES OF SALBUTAMOL SULFATE

Objective: Appropriateness of administration and patient complaints are important factors in developing dosage forms, especially for children and elderly people. The goal of this research was to develop salbutamol sulfate granules that dissolve quickly to improve patient compliance. Methods: Five formulas (F1-F5) were prepared by wet granulation methods. Different type of excipients was used in the formulation like banana powder as super disinterring, mannitol, hydroxyl propyl methylcellulose; etc. The formulas were evaluated for flow properties, drug compatibility study by FTIR, drug content, and drug release profile. Results: The result revealed that the flowability of the five formulas has accepted flow properties; The FTIR studies of the formula F2 showed no drug-excipients interaction. All of the prepared formulas show an acceptable range of drug content, a rapid release of drug of about 95.2% within 10 min. These results indicate good and rapid release properties of salbutamol sulfate from fast dissolving granules. Conclusion: Salbutamol sulfate was successfully formulated as fast-dissolving granules by using banana powder

IPv6 Security Issues: A Systematic Review Following PRISMA Guidelines

Since Internet Protocol version 6 is a new technology, insecure network configurations are inevitable. The researchers contributed a lot to spreading knowledge about IPv6 vulnerabilities and how to address them over the past two decades. In this study, a systematic literature review is conducted to analyze research progress in IPv6 security field following the Preferred Reporting Items for the Systematics Review and Meta-Analysis (PRISMA) method. A total of 427 studies have been reviewed from two databases, IEEE and Scopus. To fulfil the review goal, several key data elements were extracted from each study and two kinds of analysis were administered: descriptive analysis and literature classification. The results show positive signs of the research contributions in the field, and generally, they could be considered as a reference to explore the research of in the past two decades in IPv6 security field and to draw the future directions. For example, the percentage of publishing increased from 147 per decade from 2000-2010 to 330 per decade from 2011 to 2020 which means that the percentage increase was 124%. The number of citations is another key finding that reflects the great global interest in research devoted to IPv6 security issues, as it was 409 citations in the decade from 2000-2010, then increased to 1643 citations during the decade from 2011 to 2020, that is, the percentage increase was 302%

Response of seedling barley (Hurdeom vulgar, L.) to foliar fertilization of nano-oxides (Fe, Cu, Mg)

Background. An experiment was conducted at the Grain Technology Laboratory, Crop Department, Faculty of Agriculture, Omar Al-Mukhtar University, during the 2023 season. The experiment utilized a completely randomized design to study the response of barley to foliar application of fine nanoscale iron, manganese, and copper fertilizers. The application was carried out as foliar spray at two different doses, two weeks and one month after sowing, using 3 kg capacity pots with 20 seeds per pot. The experiment included three observations for each treatment, with the nanoscale iron, manganese, and copper oxides applied at a concentration of 1 cmol/L. The data revealed the following: Significant positive response of barley shoots to foliar application of nanoscale iron, manganese, and copper fertilizers in various growth indicators, including shoot weight, shoot length, leaf area, crop growth rate, and specific leaf weight. High significant differences were observed in the effect of nanoscale iron, manganese, and copper oxides on the average shoot weight, crop growth rate, and leaf area. Copper oxide and manganese oxide showed the highest means, followed by iron oxide, compared to the control. Iron oxide exhibited the highest specific leaf weight for barley shoots, followed by copper oxide and then manganese oxide, compared to the control treatment

Retrieval of individual patient data depended on study characteristics : a randomized controlled trial

OBJECTIVE: To examine the effect of providing a financial incentive to authors of randomized clinical trials (RCTs) to obtain individual patient data (IPD). STUDY DESIGN AND SETTING: Parallel-group RCT with authors identified in the RCTs eligible for two systematic reviews. The authors were randomly allocated to the intervention (financial incentive with several contact approaches) or control group (using the same contact approaches). Studied outcomes: proportion of authors who provided IPD, time to obtain IPD, and completeness of IPD received. RESULTS: Of the 129 authors contacted, 37 authors suggested or contacted a person/funder providing relevant details or showed interest to collaborate, while 45 authors directed us to contact a person/funder, lacked resources/time, did not have ownership/approval to share the IPD, or claimed IPD was too old. None of the authors shared their IPD. We contacted 17 sponsors and received two complete IPD datasets from one sponsor. The time to obtain IPD was >1 year after a sponsor's positive response. Common barriers included study identification, data ownership, limited data access, and required IPD licenses. CONCLUSIONS: IPD sharing may depend on study characteristics, including funding type, study size, study risk of bias, and treatment effect, but not on providing a financial incentive. TRIAL REGISTRATION: Clinical Trials.gov (NCT02569411), registered on October 5th, 2015

Integration of transcriptome and metabolome provides unique insights to pathways associated with obese breast cancer patients

Information regarding transcriptome and metabolome has significantly contributed to identifying potential therapeutic targets for the management of a variety of cancers. Obesity has profound effects on both cancer cell transcriptome and metabolome that can affect the outcome of cancer therapy. The information regarding the potential effects of obesity on breast cancer (BC) transcriptome, metabolome, and its integration to identify novel pathways related to disease progression are still elusive. We assessed the whole blood transcriptome and serum metabolome, as circulating metabolites, of obese BC patients compared them with non-obese BC patients. In these patients' samples, 186 significant differentially expressed genes (DEGs) were identified, comprising 156 upregulated and 30 downregulated. The expressions of these gene were confirmed by qRT-PCR. Furthermore, 96 deregulated metabolites were identified as untargeted metabolomics in the same group of patients. These detected DEGs and deregulated metabolites enriched in many cellular pathways. Further investigation, by integration analysis between transcriptomics and metabolomics data at the pathway levels, revealed seven unique enriched pathways in obese BC patients when compared with non-obese BC patients, which may provide resistance for BC cells to dodge the circulating immune cells in the blood. In conclusion, this study provides information on the unique pathways altered at transcriptome and metabolome levels in obese BC patients that could provide an important tool for researchers and contribute further to knowledge on the molecular interaction between obesity and BC. Further studies are needed to confirm this and to elucidate the exact underlying mechanism for the effects of obesity on the BC initiation or/and progression

Moving the Needle Toward Fair Compensation in Pediatric Nephrology

Remuneration issues are a substantial threat to the long-term stability of the pediatric nephrology workforce. It is uncertain whether the pediatric nephrology workforce will meet the growing needs of children with kidney disease without a substantial overhaul of the current reimbursement policies. In contrast to adult nephrology, the majority of pediatric nephrologists practice in an academic setting affiliated with a university and/or children's hospital. The pediatric nephrology service line is crucial to maintaining the financial health and wellness of a comprehensive children's hospital. However, in the current fee-for-service system, the clinical care for children with kidney disease is neither sufficiently valued, nor appropriately compensated. Current compensation models derived from the relative value unit (RVU) system contribute to the structural biases inherent in the current inequitable payment system. The perceived negative financial compensation is a significant driver of waning trainee interest in the field which is one of the least attractive specialties for students, with a significant proportion of training spots going unfilled each year and relatively stagnant growth rate as compared to the other pediatric subspecialties. This article reviews the current state of financial compensation issues plaguing the pediatric nephrology subspecialty. We further outline strategies for pediatric nephrologists, hospital administrators, and policy-makers to improve the landscape of financial reimbursement to pediatric subspecialists. A physician compensation model is proposed which aligns clinical activity with alternate metrics for current non-RVU producing activities that harmonizes hospital and personal mission statements

Low-Dose Antithymocyte Globulin Has No Disadvantages to Standard Higher Dose in Pediatric Kidney Transplant Recipients: Report from the Pediatric Nephrology Research Consortium

Introduction Rabbit antithymocyte globulin (rATG) dosing strategies for induction in pediatric kidney transplantation vary between centers. It is not known whether a lower rATG induction dose provides safe and effective immunosuppression compared with a “standard” higher dose. Methods We performed a retrospective multicenter study of all isolated first-time kidney transplant recipients \u3c 21 years old who received rATG induction between 1 January 2010 and 31 December 2014 at 9 pediatric centers. An a priori cutoff of a 4.5-mg/kg cumulative rATG dose was used to identify low (≤ 4.5 mg/kg) and standard (\u3e 4.5 mg/kg) exposure groups. Outcomes examined included 12 months posttransplant graft function (estimated glomerular filtration rate [eGFR]); the occurrence of acute rejection, donor-specific antibody (DSA), neutropenia, and viral infection (cytomegalovirus [CMV], Epstein-Barr virus [EBV], and BK virus); and 24-month outcomes of posttransplant lymphoproliferative disorder (PTLD) occurrence and patient and graft survival. Results Two hundred thirty-five patients were included. Baseline features of the low and standard rATG dose groups were similar. By 12 months, the rATG dose group had no significant impact on the occurrence of neutropenia, positive DSA, or viral polymerase chain reaction (PCR). Graft function was similar. Acute rejection rates were similar at 17% (low dose) versus 19% (standard dose) (P = 0.13). By 24 months, graft survival (96.4% vs. 94.6%) and patient survival (100% vs. 99.3%) were similar between the low- and standard-dose groups (P = 0.54 and 0.46), whereas the occurrence of PTLD trended higher in the standard-dose group (0% vs. 2.6%, P = 0.07). Conclusion A low rATG induction dose ≤ 4.5 mg/kg provided safe and effective outcomes in this multicenter low immunologic risk pediatric cohort. Prospective studies are warranted to define the optimal rATG induction dose in pediatric kidney transplantation